| Sept. 17, 2025 |
Lauren Prack - JHH |
SMA Pharmacotherapy: From IT to IV to PO |
| Sept. 17, 2025 |
Cole Swartz – JHH |
TIL-ting the Scales: Balancing Efficacy and Safety of Cellular Immunotherapy |
| Sept. 24, 2025 |
Tom Diaz - JHH |
|
| Sept. 25, 2024 |
Alex Killough - JHH |
Taking a BiTE out of Small Cell Lung Cancer |
| Oct. 1, 2025 |
Tiffany Dinh – JHH |
Smart Pump Interoperability: Infusing Safety, One Interface at a Time |
| Oct. 1, 2025 |
Jennifer Zhao – JHCH |
Implications of Pharmaceutical Tariffs on Drug Supply Chain and Access |
| Oct. 8, 2025 |
Madison Anderson – JHH |
REMS-less but Not Risk-less: Clozapine Monitoring in a Post-REMS Era |
| Oct. 8, 2025 |
John Fattal - JHH |
Emerging Therapies in Transthyretin Amyloid Cardiomyopathy  |
| Oct. 15, 2025 |
Shay Roth – JHH |
The Sweet Spot: Utilization of Continuous Glucose Monitoring Devices Inpatient |
| Oct. 15, 2025 |
Kate Stevenson - JHH |
|
| Oct. 23, 2024 |
John Fattal - JHH |
Re-Evaluating Beta Blockers Post-MI |
| Oct. 22, 2025 |
Sadora Franklin - JHH |
Pharmacotherapy guidance for cocaine use disorder  |
| Oct. 22, 2025 |
Deslynne Henkel - JHH |
From TOPCAT to FINEARTS-HF: Finerenone’s Moment in HFpEF |
| Oct. 29, 2025 |
Shekinah Banson - JHCH |
Optimizing Buprenorphine Formulations: The Role of the Pharmacist in Long-Acting Injectable Therapy for Opioid Use Disorder (OUD) |
| Oct. 29, 2025 |
Amrit Pabla - JHBMC |
Immune checkpoint inhibitors in pre-existing autoimmune diseases |
| Nov. 5, 2025 |
Mikayla Mariano - JHH |
GvHD Happy Hour: AGAVE on the ROCKs |
| Nov. 5, 2025 |
Dajeon (John) Kim-Suburban |
Suzetrigine, a new class of oral non-opioid analgesics |
| Nov. 12, 2025 |
Yurim Ko - Sibley |
Cystic Fibrosis Gene Therapies |
| Nov. 12, 2025 |
Razan Fannoun - JHH |
|
| Nov. 19, 2025 |
Kaitlyn Gelb - JHCH |
Beyond First-Line Therapy: The Role of Memantine in Obsessive-Compulsive Disorder |
| Nov. 19, 2025 |
Michael Snitzer - JHCH |
Should I RSV-P?: Respiratory Syncytial Virus (RSV) Vaccine Hesitancy in Older Adults |
| Nov. 26, 2025 |
No rounds - Thanksgiving |
|
| Dec. 3, 2025 |
Reagan Schlierf - JHBMC |
Risk of stimulant-induced psychosis or mania in the treatment of bipolar disorder and ADHD |
| Dec. 3, 2025 |
Charlotte Spry - JHBMC |
Updated Plumbing: Changes in the Management of Complicated UTIs |
| Dec. 10, 2025 |
No rounds - Midyear |
|
| Dec. 17, 2025 |
Debika Kundu - JHH |
To DO(AC) or Not to DO(AC): Anticoagulation Challenges in TIPS Patients |
| Dec. 17, 2025 |
Lucas O’Brien - JHH |
Lenacapavir – Yeztugo for PrEP of HIV-1 |
| Dec. 24, 2025 |
No rounds - Winter holiday |
|
| Dec. 31, 2025 |
No rounds - New Year's Eve |
|
| Jan. 7, 2026 |
Deanna Guan - JHH |
From Bench to Bedside: Translating Science into Hope for Huntington’s Disease |
| Jan. 7, 2026 |
SeHan Jeong - JHH |
Iptacopan for Immunoglobulin A Nephropathy |
| Jan. 14, 2026 |
Corinne Berkery - JHH |
(A)Fire and Water: Making Waves in Antiplatelet Therapy for Chronic Coronary Disease |
| Jan. 21, 2026 |
Joseph Robinson - JHH |
|
| Jan. 21, 2026 |
Grace Ukazim - JHH |
|
| Jan. 28, 2026 |
Caroline Fan - JHH |
Bv-AVD versus N-AVD in Hodgkin Lymphoma |
| Jan. 28, 2026 |
Catherine Smith - JHH |
Macrolide Therapy in Non-Severe Community-Acquired Pneumonia |
| March 5, 2025 |
Jodi Ann Gayle – Sibley |
Atypical Hemolytic Uremic Syndrome |
| March 4, 2026 |
Dasia Simmons - Sibley |
|
| March 4, 2026 |
Rhoda Takyi - Sibley |
|
| March 11, 2026 |
McKinzie Sprague - JHACH |
Can't Gatekeep Any Longer: CFTR Modulators Inflience on CF |
| March 11, 2026 |
Jesse Klus - JHACH |
Small Patients, Big Updates: Navigating New Directions in Pediatric nPEP Practice |
| March 18, 2026 |
Emily Baraclough - JHH |
|
| March 18, 2026 |
Alexander Coughlin - JHH |
|
| March 25, 2026 |
Mojibola Awe - JHH |
|
| March 25, 2026 |
Roxanna Vassighi - JHH |
|
| April 1, 2026 |
Jae Young Sohn - JHHC |
Expanding Treatment Options for Uncomplicated Urogenital Gonorrhea with New Oral Antibiotics |
| April 1, 2026 |
Emmy Zhao - JHHC |
HIV PrEP, title "Daily Pills to Twice Yearly Thrills: Lenacapavir for PrEP |
| April 8, 2026 |
Meade Avery - JHH |
The Utilization of Hepatitis B Viremic Donors in Thoracic Transplant |
| April 8, 2026 |
Eric Mackin - JHH |
The Utility of Vitamin A in Measles Treatment |
| April 15, 2026 |
Elizabeth Remizowski - JHH |
Vasoactive Adjuncts for Refractory Septic Shock |
| April 15, 2026 |
Sarah Hou - JHH |
Low-Dose, High-Impact: Exploring the Role of Low-Dose Naltrexone in Long COVID Management |
| April 22, 2026 |
Make up date if needed |
|
| April 29, 2026 |
Make up date if needed |
|
